![Trump to impose 25% tariffs on automobiles, pharmaceuticals, and chips](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEKBJ0R5_L.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1045 | 1127 | 1250 | 987 | 1512 | - |
Fund Return | 4.49% | 12.68% | 25.04% | -0.45% | 8.63% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0171289225 | 1.06B | -2.00 | 11.25 | 6.96 | ||
LU0331284793 | 364.34M | 2.74 | 2.28 | 3.69 | ||
Global Allocation Fund X2 Use | 881.6M | 10.70 | 2.55 | 6.48 | ||
LU0408221512 | 1.34B | 2.84 | 3.57 | 4.99 | ||
LU0523293024 | 1.17B | 2.89 | 4.34 | 5.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 67.17B | 2.19 | 12.49 | 8.04 | ||
Invesco JapEqAdvantage C EUR H AccE | 67.17B | 2.26 | 13.46 | 8.89 | ||
LU1841614867 | 286.15M | 3.54 | 11.65 | - | ||
LU1482751903 | 472.89M | 19.62 | 9.30 | - | ||
Morgan Stanley Global Brands CH | 20.82B | 4.84 | 1.41 | 6.56 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
NVIDIA | US67066G1040 | 9.09 | 139.40 | +0.40% | |
Astera Labs | US04626A1034 | 4.93 | 93.27 | +6.17% | |
US75734B1008 | 3.36 | 187.13 | -4.71% | ||
Credo Technology Group Holding Ltd | - | 3.36 | - | - | |
Tesla | US88160R1014 | 3.08 | 354.11 | -0.49% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review